358
Views
0
CrossRef citations to date
0
Altmetric
Pediatric Nephrology

Clinical features and genetic analysis of 15 Chinese children with dent disease

, , , , , , , & show all
Article: 2349133 | Received 20 Nov 2023, Accepted 19 Apr 2024, Published online: 10 May 2024

References

  • Wang Y, Xu L, Zhang Y, et al. Dent disease 1-linked novel CLCN5 mutations result in aberrant location and reduced ion currents. Int J Biol Macromol. 2024;257(Pt 2):1. doi: 10.1016/j.ijbiomac.2023.128564.
  • Gianesello L, Del Prete D, Anglani F, et al. Genetics and phenotypic heterogeneity of dent disease: the dark side of the moon. Hum Genet. 2021;140(3):401–10. doi: 10.1007/s00439-020-02219-2.
  • Wong W, Poke G, Stack M, et al. Phenotypic variability of dent disease in a large New Zealand kindred. Pediatr Nephrol. 2017;32(2):365–369. doi: 10.1007/s00467-016-3472-8.
  • Jin YY, Huang LM, Quan XF, et al. Dent disease: classification, heterogeneity and diagnosis. World J Pediatr. 2021;17(1):52–57. doi: 10.1007/s12519-020-00357-1.
  • Sakakibara N, Nagano C, Ishiko S, et al. Comparison of clinical and genetic characteristics between dent disease 1 and dent disease 2. Pediatr Nephrol. 2020;35(12):2319–2326. doi: 10.1007/s00467-020-04701-5.
  • Picollo A, Pusch M. Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. Nature. 2005; 436(7049):420–423. doi: 10.1038/nature03720.
  • De Matteis MA, Staiano L, Emma F, et al. The 5-phosphatase OCRL in lowe syndrome and dent disease 2. Nat Rev Nephrol. 2017;13(8):455–470. doi: 10.1038/nrneph.2017.83.
  • Ehlayel AM, Copelovitch L. Update on dent disease. Pediatr Clin North Am. 2019;66(1):169–178. doi: 10.1016/j.pcl.2018.09.003.
  • Claverie-Martín F, Ramos-Trujillo E, García-Nieto V. Dent’s disease: clinical features and molecular basis. Pediatr Nephrol. 2011;26(5):693–704. doi: 10.1007/s00467-010-1657-0.
  • Drosataki E, Maragkou S, Dermitzaki K, et al. Dent-2 disease with a bartter-like phenotype caused by the Asp631Glu mutation in the OCRL gene. BMC Nephrol. 2022;23(1):182. doi: 10.1186/s12882-022-02812-9.
  • Ye Q, Shen Q, Rao J et al. Multicenter study of the clinical features and mutation gene spectrum of Chinese children with dent disease. Clin Genet. 2020;97(3):407–417. doi: 10.1111/cge.13663.
  • Burballa C, Cantero-Recasens G, Prikhodina L, et al. Clinical and genetic characteristics of dent’s disease type 1 in Europe. Nephrol Dial Transplant. 2023;38(6):1497–1507. doi: 10.1093/ndt/gfac310.
  • Zhang Y, Fang XY, Xu H, et al. Five case series of dent-1 disease and literature review. Chin J Evid-Based Pediatr. 2016;11(5):382–387. doi: 10.3969/j.issn.1673-5501.2016.05.014.
  • Leite de Sousa L, Pimenta G, Veríssimo R, et al. Dent’s disease: an unusual cause of kidney failure. Clin Nephrol Case Stud. 2023;11(1):1–5. doi: 10.5414/CNCS110975.
  • Trautmann A, Lipska-Ziętkiewicz BS, Schaefer F. Exploring the clinical and genetic spectrum of steroid resistant nephrotic syndrome: the PodoNet registry. Front Pediatr. 2018;6:200. doi: 10.3389/fped.2018.00200.
  • Sekine T, Komoda F, Miura K, et al. Japanese dent disease has a wider clinical spectrum than dent disease in Europe/USA: genetic and clinical studies of 86 unrelated patients with low-molecular-weight proteinuria. Nephrol Dial Transplant. 2014;29(2):376–384. doi: 10.1093/ndt/gft394.
  • Bezdíčka M, Langer J, Háček J, et al. Dent disease type 2 as a cause of focal segmental glomerulosclerosis in a 6-Year-Old boy: a case report. Front Pediatr. 2020;8:583230. doi: 10.3389/fped.2020.583230.
  • Wang X, Anglani F, Beara-Lasic L, et al. Glomerular pathology in dent disease and its association with kidney function. Clin J Am Soc Nephrol. 2016;11(12):2168–2176. doi: 10.2215/CJN.03710416.
  • Huang LM, Mao JH. Glomerular podocyte dysfunction in inherited renal tubular disease. World J Pediatr. 2021;17(3):227–233. doi: 10.1007/s12519-021-00417-0.
  • Zhang Y, Fang X, Xu H, et al. Genetic analysis of dent’s disease and functional research of CLCN5 mutations. DNA Cell Biol. 2017;36(12):1151–1158. doi: 10.1089/dna.2017.3731.
  • Mansour-Hendili L, Blanchard A, Le Pottier N, et al. Mutation update of the CLCN5 gene responsible for dent disease 1. Hum Mutat. 2015;36(8):743–752. doi: 10.1002/humu.22804.
  • Wu F, Reed AA, Williams SE, et al. Mutational analysis of CLC-5, cofilin and CLC-4 in patients with dent’s disease. Nephron Physiol. 2009;112(4):p53–62. doi: 10.1159/000225944.
  • Ludwig M, Doroszewicz J, Seyberth HW, et al. Functional evaluation of dent’s disease-causing mutations: implications for ClC-5 channel trafficking and internalization. Hum Genet. 2005;117(2-3):228–237. doi: 10.1007/s00439-005-1303-2.
  • Smith AJ, Reed AA, Loh NY, et al. Characterization of dent’s disease mutations of CLC-5 reveals a correlation between functional and cell biological consequences and protein structure. Am J Physiol Renal Physiol. 2009;296(2):F390–7. doi: 10.1152/ajprenal.90526.2008.
  • Gianesello L, Arroyo J, Del Prete D, et al. Genotype phenotype correlation in dent disease 2 and review of the literature: OCRL gene pleiotropism or extreme phenotypic variability of lowe syndrome? Genes . 2021;12(10):1597. doi: 10.3390/genes12101597.
  • Mura-Escorche G, Perdomo-Ramírez A, Ramos-Trujillo E, et al. Characterization of pre-mRNA splicing defects caused by CLCN5 and OCRL mutations and identification of novel variants associated with dent disease. Biomedicines. 2023;11(11):3082. doi: 10.3390/biomedicines11113082.
  • van Rahden VA, Brand K, Najm J, et al. The 5-phosphatase OCRL mediates retrograde transport of the mannose 6-phosphate receptor by regulating a Rac1-cofilin signalling module. Hum Mol Genet. 2012;21(23):5019–5038. doi: 10.1093/hmg/dds343.
  • Zaniew M, Bökenkamp A, Kolbuc M, et al. Long-term renal outcome in children with OCRL mutations: retrospective analysis of a large international cohort. Nephrol Dial Transplant. 2018;33(1):85–94. doi: 10.1093/ndt/gfw350.
  • Blanchard A, Curis E, Guyon-Roger T, et al. Observations of a large dent disease cohort. Kidney Int. 2016;90(2):430–439. doi: 10.1016/j.kint.2016.04.022.
  • Zaniew M, Mizerska-Wasiak M, Załuska-Leśniewska I, et al. Dent disease in Poland: what we have learned so far? Int Urol Nephrol. 2017;49(11):2005–2017. doi: 10.1007/s11255-017-1676-x.
  • Akuta N, Lloyd SE, Igarashi T, et al. Mutations of CLCN5 in Japanese children with idiopathic low molecular weight proteinuria, hypercalciuria and nephrocalcinosis. Kidney Int. 1997;52(4):911–916. doi: 10.1038/ki.1997.412.
  • Hoopes RR, Jr, Raja KM, Koich A, et al. Evidence for genetic heterogeneity in dent’s disease. Kidney Int. 2004;65(5):1615–1620. doi: 10.1111/j.1523-1755.2004.00571.x.
  • Lourdel S, Grand T, Burgos J, et al. ClC-5 mutations associated with dent’s disease: a major role of the dimer interface. Pflugers Arch. 2012;463(2):247–256. doi: 10.1007/s00424-011-1052-0.
  • Domingo-Gallego A, Pybus M, Bullich G, et al. Clinical utility of genetic testing in early-onset kidney disease: seven genes are the main players. Nephrol Dial Transplant. 2022;37(4):687–696. doi: 10.1093/ndt/gfab019.
  • Ranawaka R, Sirisena ND, Dayasiri KC, et al. The first Sri Lankan family with dent disease-1 due to a pathogenic variant in the CLCN5 gene: a case report. BMC Res Notes. 2017;10(1):539. doi: 10.1186/s13104-017-2881-5.
  • Gambaro G, Naticchia A, Ferraro PM, et al. Living kidney donation in a type 1 dent’s disease patient from his mother. Kidney Blood Press Res. 2019;44(5):1306–1312. doi: 10.1159/000503301.
  • Ramos-Trujillo E, González-Acosta H, Flores C, et al. A missense mutation in the chloride/proton ClC-5 antiporter gene results in increased expression of an alternative mRNA form that lacks exons 10 and 11. Identification of seven new CLCN5 mutations in patients with dent’s disease. J Hum Genet. 2007;52(3):255–261. doi: 10.1007/s10038-007-0112-y.
  • Utsch B, Bökenkamp A, Benz MR, et al. Novel OCRL1 mutations in patients with the phenotype of dent disease. Am J Kidney Dis. 2006;48(6):942.e1-14–942.14. Dec doi: 10.1053/j.ajkd.2006.08.018.
  • Hoopes RR, Jr, Shrimpton AE, Knohl SJ, et al. Dent disease with mutations in OCRL1. Am J Hum Genet. 2005;76(2):260–267. doi: 10.1086/427887.
  • Hichri H, Rendu J, Monnier N, et al. From lowe syndrome to dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Hum Mutat. 2011;32(4):379–388. doi: 10.1002/humu.21391.